Antibody Derived Peptides for Detection of Ebola Virus Glycoprotein

Background Current Ebola virus (EBOV) detection methods are costly and impractical for epidemic scenarios. Different immune-based assays have been reported for the detection and quantification of Ebola virus (EBOV) proteins. In particular, several monoclonal antibodies (mAbs) have been described th...

Full description

Bibliographic Details
Main Authors: Rodriguez-Martinez, Luis Mario, Marquez-Ipina, Alan Roberto, Lopez-Pacheco, Felipe, Perez-Chavarria, Roberto, Gonzalez-Vazquez, Juan Carlos, Gonzalez-Gonzalez, Everardo, Trujillo-de Santiago, Grissel, Ponce-Ponce de Leon, Cesar Alejandro, Zhang, Yu Shrike, Dokmeci, Mehmet Remzi, Khademhosseini, Ali, Alvarez, Mario Moises
Other Authors: Harvard University--MIT Division of Health Sciences and Technology
Format: Article
Language:en_US
Published: Public Library of Science 2015
Online Access:http://hdl.handle.net/1721.1/99735
_version_ 1826195749328650240
author Rodriguez-Martinez, Luis Mario
Marquez-Ipina, Alan Roberto
Lopez-Pacheco, Felipe
Perez-Chavarria, Roberto
Gonzalez-Vazquez, Juan Carlos
Gonzalez-Gonzalez, Everardo
Trujillo-de Santiago, Grissel
Ponce-Ponce de Leon, Cesar Alejandro
Zhang, Yu Shrike
Dokmeci, Mehmet Remzi
Khademhosseini, Ali
Alvarez, Mario Moises
author2 Harvard University--MIT Division of Health Sciences and Technology
author_facet Harvard University--MIT Division of Health Sciences and Technology
Rodriguez-Martinez, Luis Mario
Marquez-Ipina, Alan Roberto
Lopez-Pacheco, Felipe
Perez-Chavarria, Roberto
Gonzalez-Vazquez, Juan Carlos
Gonzalez-Gonzalez, Everardo
Trujillo-de Santiago, Grissel
Ponce-Ponce de Leon, Cesar Alejandro
Zhang, Yu Shrike
Dokmeci, Mehmet Remzi
Khademhosseini, Ali
Alvarez, Mario Moises
author_sort Rodriguez-Martinez, Luis Mario
collection MIT
description Background Current Ebola virus (EBOV) detection methods are costly and impractical for epidemic scenarios. Different immune-based assays have been reported for the detection and quantification of Ebola virus (EBOV) proteins. In particular, several monoclonal antibodies (mAbs) have been described that bind the capsid glycoprotein (GP) of EBOV GP. However, the currently available platforms for the design and production of full-length mAbs are cumbersome and costly. The use of antibody fragments, rather than full-length antibodies, might represent a cost-effective alternative for the development of diagnostic and possibly even therapeutic alternatives for EBOV. Methods/Principal Findings We report the design and expression of three recombinant anti-GP mAb fragments in Escherichia coli cultures. These fragments contained the heavy and light variable portions of the three well-studied anti-GP full-length mAbs 13C6, 13F6, and KZ52, and are consequently named scFv-13C6, scFv-13F6, and Fab-KZ52, respectively. All three fragments exhibited specific anti-GP binding activity in ELISA experiments comparable to that of full-length anti-GP antibodies (i.e., the same order of magnitude) and they are easily and economically produced in bacterial cultures. Conclusion/Significance Antibody fragments might represent a useful, effective, and low cost alternative to full-length antibodies in Ebola related capture and diagnostics applications.
first_indexed 2024-09-23T10:14:50Z
format Article
id mit-1721.1/99735
institution Massachusetts Institute of Technology
language en_US
last_indexed 2024-09-23T10:14:50Z
publishDate 2015
publisher Public Library of Science
record_format dspace
spelling mit-1721.1/997352022-09-30T19:52:16Z Antibody Derived Peptides for Detection of Ebola Virus Glycoprotein Rodriguez-Martinez, Luis Mario Marquez-Ipina, Alan Roberto Lopez-Pacheco, Felipe Perez-Chavarria, Roberto Gonzalez-Vazquez, Juan Carlos Gonzalez-Gonzalez, Everardo Trujillo-de Santiago, Grissel Ponce-Ponce de Leon, Cesar Alejandro Zhang, Yu Shrike Dokmeci, Mehmet Remzi Khademhosseini, Ali Alvarez, Mario Moises Harvard University--MIT Division of Health Sciences and Technology Dokmeci, Mehmet Remzi Khademhosseini, Ali Background Current Ebola virus (EBOV) detection methods are costly and impractical for epidemic scenarios. Different immune-based assays have been reported for the detection and quantification of Ebola virus (EBOV) proteins. In particular, several monoclonal antibodies (mAbs) have been described that bind the capsid glycoprotein (GP) of EBOV GP. However, the currently available platforms for the design and production of full-length mAbs are cumbersome and costly. The use of antibody fragments, rather than full-length antibodies, might represent a cost-effective alternative for the development of diagnostic and possibly even therapeutic alternatives for EBOV. Methods/Principal Findings We report the design and expression of three recombinant anti-GP mAb fragments in Escherichia coli cultures. These fragments contained the heavy and light variable portions of the three well-studied anti-GP full-length mAbs 13C6, 13F6, and KZ52, and are consequently named scFv-13C6, scFv-13F6, and Fab-KZ52, respectively. All three fragments exhibited specific anti-GP binding activity in ELISA experiments comparable to that of full-length anti-GP antibodies (i.e., the same order of magnitude) and they are easily and economically produced in bacterial cultures. Conclusion/Significance Antibody fragments might represent a useful, effective, and low cost alternative to full-length antibodies in Ebola related capture and diagnostics applications. National Science Foundation (U.S.) (EFRI-1240443) IMMODGEL 602694 National Institutes of Health (U.S.) (EB012597) National Institutes of Health (U.S.) (AR057837) National Institutes of Health (U.S.) (DE021468) National Institutes of Health (U.S.) (HL099073) National Institutes of Health (U.S.) (AI105024) National Institutes of Health (U.S.) (AR063745) 2015-11-05T18:29:12Z 2015-11-05T18:29:12Z 2015-10 2015-03 Article http://purl.org/eprint/type/JournalArticle 1932-6203 http://hdl.handle.net/1721.1/99735 Rodriguez-Martinez, Luis Mario, Alan Roberto Marquez-Ipina, Felipe Lopez-Pacheco, Roberto Perez-Chavarria, Juan Carlos Gonzalez-Vazquez, Everardo Gonzalez-Gonzalez, Grissel Trujillo-de Santiago, et al. “Antibody Derived Peptides for Detection of Ebola Virus Glycoprotein.” Edited by Gourapura J Renukaradhya. PLoS ONE 10, no. 10 (October 21, 2015): e0135859. en_US http://dx.doi.org/10.1371/journal.pone.0135859 PLOS ONE Creative Commons Attribution http://creativecommons.org/licenses/by/4.0/ application/pdf Public Library of Science Public Library of Science
spellingShingle Rodriguez-Martinez, Luis Mario
Marquez-Ipina, Alan Roberto
Lopez-Pacheco, Felipe
Perez-Chavarria, Roberto
Gonzalez-Vazquez, Juan Carlos
Gonzalez-Gonzalez, Everardo
Trujillo-de Santiago, Grissel
Ponce-Ponce de Leon, Cesar Alejandro
Zhang, Yu Shrike
Dokmeci, Mehmet Remzi
Khademhosseini, Ali
Alvarez, Mario Moises
Antibody Derived Peptides for Detection of Ebola Virus Glycoprotein
title Antibody Derived Peptides for Detection of Ebola Virus Glycoprotein
title_full Antibody Derived Peptides for Detection of Ebola Virus Glycoprotein
title_fullStr Antibody Derived Peptides for Detection of Ebola Virus Glycoprotein
title_full_unstemmed Antibody Derived Peptides for Detection of Ebola Virus Glycoprotein
title_short Antibody Derived Peptides for Detection of Ebola Virus Glycoprotein
title_sort antibody derived peptides for detection of ebola virus glycoprotein
url http://hdl.handle.net/1721.1/99735
work_keys_str_mv AT rodriguezmartinezluismario antibodyderivedpeptidesfordetectionofebolavirusglycoprotein
AT marquezipinaalanroberto antibodyderivedpeptidesfordetectionofebolavirusglycoprotein
AT lopezpachecofelipe antibodyderivedpeptidesfordetectionofebolavirusglycoprotein
AT perezchavarriaroberto antibodyderivedpeptidesfordetectionofebolavirusglycoprotein
AT gonzalezvazquezjuancarlos antibodyderivedpeptidesfordetectionofebolavirusglycoprotein
AT gonzalezgonzalezeverardo antibodyderivedpeptidesfordetectionofebolavirusglycoprotein
AT trujillodesantiagogrissel antibodyderivedpeptidesfordetectionofebolavirusglycoprotein
AT ponceponcedeleoncesaralejandro antibodyderivedpeptidesfordetectionofebolavirusglycoprotein
AT zhangyushrike antibodyderivedpeptidesfordetectionofebolavirusglycoprotein
AT dokmecimehmetremzi antibodyderivedpeptidesfordetectionofebolavirusglycoprotein
AT khademhosseiniali antibodyderivedpeptidesfordetectionofebolavirusglycoprotein
AT alvarezmariomoises antibodyderivedpeptidesfordetectionofebolavirusglycoprotein